These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10802376)

  • 21. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
    Thomas C; Lartigau E; Malaise EP; Guichard M
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1157-60. PubMed ID: 2497094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI.
    Jordan BF; Misson P; Demeure R; Baudelet C; Beghein N; Gallez B
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):565-70. PubMed ID: 10974477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. fMRI for monitoring dynamic changes in tissue oxygenation/blood flow: potential applications for tumor response to carbogen treatment.
    Zhong J; Kwok WC; Okunieff P
    Adv Exp Med Biol; 2003; 530():449-59. PubMed ID: 14562740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors
    Xiang Y; Bernards N; Hoang B; Zheng J; Matsuura N
    Nanotheranostics; 2019; 3(2):135-144. PubMed ID: 31008022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of rat brain tumor therapy by fluosol and carbogen.
    Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
    NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of tumor oxygenation by mild hyperthermia.
    Song CW; Park H; Griffin RJ
    Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
    Grau C; Horsman MR; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):415-9. PubMed ID: 1735671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in tumor response to fluosol-DA (20%).
    Sasai K; Ono K; Nishidai T; Tsutsui K; Shibamoto Y; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1149-52. PubMed ID: 2497093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity.
    Thomas C; Riess J; Guichard M
    Int J Radiat Biol; 1991 Feb; 59(2):433-45. PubMed ID: 1671693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen.
    Song CW; Shakil A; Griffin RJ; Okajima K
    Semin Oncol; 1997 Dec; 24(6):626-32. PubMed ID: 9422259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of carbogen on tumour oxygenation and 32P-colloid interstitial irradiation response.
    Zhan HW; Liu HB; Bao CK; Ye XJ; Zhang H; He GQ
    Med Sci Monit; 2010 Jan; 16(1):BR11-6. PubMed ID: 20037480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of visually evoked BOLD responses during carbogen inhalation: implications for calibrated MRI.
    Gauthier CJ; Madjar C; Tancredi FB; Stefanovic B; Hoge RD
    Neuroimage; 2011 Jan; 54(2):1001-11. PubMed ID: 20887792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
    Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
    J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring Tumor Response to Carbogen Breathing by Oxygen-Sensitive Magnetic Resonance Parameters to Predict the Outcome of Radiation Therapy: A Preclinical Study.
    Cao-Pham TT; Tran LB; Colliez F; Joudiou N; El Bachiri S; Grégoire V; Levêque P; Gallez B; Jordan BF
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):149-60. PubMed ID: 27511852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
    Teicher BA; Dupuis NP; Robinson MF; Kusumoto T; Liu M; Menon K
    In Vivo; 1994; 8(1):125-31. PubMed ID: 8054502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical evaluation of Oxygent as an adjunct to radiotherapy.
    Rockwell S; Kelley M; Irvin CG; Hughes CS; Yabuki H; Porter E; Fischer JJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):883-93. PubMed ID: 1391528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA; Herman TS; Holden SA; Jones SM
    J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined endogenous MR biomarkers to predict basal tumor oxygenation and response to hyperoxic challenge.
    Cao-Pham TT; Joudiou N; Van Hul M; Bouzin C; Cani PD; Gallez B; Jordan BF
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 29024086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.